FactaeThe Factual News

Inventiva completes treatment period for NATiV3 study

Inventiva announces the completion of the treatment period for its NATiV3 study.

Published 3h1 sourceupdated 3h

Lire en français

≈ 16sSpeed

The fact

This clinical trial targets a rare disease and could open new therapeutic avenues.

Results are expected in the coming months.

Click the link to read an article on the topic:

Explore this topic

France Inventiva #inventiva #nativ3 #étude clinique #maladie rare #biotechnologie #santé

What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.

FranceWorld map →

Follow topic →

Auto-synthesis from 1 media source · identified on September 3, 2026

← Back to home

Discover

Read more

All marches →